Clinical Trial Update: VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update indicating completion of vagal nerve stimulation for heart failure with reduced ejection fraction (sponsored by LivaNova).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• VNS Therapy System

Snippet

Sponsor: LivaNova | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 2 | Status: COMPLETED